• Cimetidine: Unlocking Translational Potential in Cancer and

  2026-05-19

  This thought-leadership article explores the unique mechanistic and translational value of Cimetidine—an H2 receptor antagonist with partial agonist activity—in gastrointestinal cancer and blood-brain barrier research. Integrating evidence from recent high-throughput BBB modeling advances and APExBIO’s high-purity offering, the piece supplies experimental and strategic guidance for translational researchers, while distinguishing itself from conventional product coverage.

• FLAG tag Peptide (DYKDDDDK): Precision in Protein Purificati

  2026-05-18

  The FLAG tag Peptide (DYKDDDDK) enables gentle, high-specificity purification and detection of recombinant proteins, streamlining workflows in molecular bioscience. This guide translates recent reference findings and best practices into actionable protocols, troubleshooting, and comparative insights that maximize yield, reproducibility, and assay flexibility.

• Verteporfin-Induced IRE1α Activation Synergizes with AKT Inh

  2026-05-18

  This study identifies verteporfin as a molecular glue that induces IRE1α dimerization and activation, leading to downstream modulation of PTEN, AKT, and BACH1 in breast cancer. The findings reveal that combining verteporfin with AKT inhibition results in synergistic suppression of tumor growth, offering mechanistic insights for therapeutic strategies targeting the unfolded protein response.

• Lipid Scrambling Regulates Ferroptosis and Tumor Immune Reje

  2026-05-17

  Yang et al. uncover TMEM16F-mediated lipid scrambling as a key suppressor of ferroptosis by orchestrating phospholipid redistribution at the plasma membrane. Inhibiting this process sensitizes tumor cells to ferroptosis and boosts immune rejection, revealing a novel axis for cancer therapy.

• Pol II Degradation Triggers Apoptosis Independent of Transcr

  2026-05-16

  This study uncovers that targeted degradation of RNA Polymerase II (Pol II) initiates apoptosis via a mechanism that does not require global transcriptional shutdown. The findings redefine how transcriptional machinery integrity is linked to cell fate, offering new conceptual frameworks for apoptosis induction in cancer research.

• BicD and MAP7 Synergize to Activate Drosophila Kinesin-1

  2026-05-15

  This study provides molecular insight into how the adaptor BicD and the microtubule-associated protein MAP7 regulate the activation of homodimeric Drosophila kinesin-1. The findings reveal complementary mechanisms relieving auto-inhibition and enhancing microtubule engagement, which has practical implications for dissecting motor protein function in cell biology.

• Tetrahydromagnolol: CB2 Agonism and Metastatic Signaling Ins

  2026-05-15

  This article explores the mechanistic and strategic frontiers of tetrahydromagnolol as a highly selective peripheral CB2 receptor agonist, emphasizing its pivotal role in anti-inflammatory and cannabinoid receptor research. Integrating the latest findings on GPCR-driven metastasis, notably the TBXA2R-ERM axis in triple-negative breast cancer, we provide translational researchers with actionable guidance and protocol recommendations. This piece distinguishes itself by bridging rigorous molecular insight with experimental strategy, extending far beyond standard product overviews.

• Sulfamonomethoxine in Veterinary & Aquatic Systems: Mechanis

  2026-05-14

  Explore Sulfamonomethoxine's advanced antibacterial mechanisms, biotransformation via cytochrome P450 and ammonia monooxygenase, and implications for veterinary and aquaculture use. This in-depth article offers a novel, systems-level perspective on SMM's role as a veterinary antibiotic and its environmental fate.

• FLAG tag Peptide: Precision in Recombinant Protein Detection

  2026-05-14

  Leverage the FLAG tag Peptide (DYKDDDDK) for streamlined recombinant protein purification, detection, and workflow reproducibility. This guide unpacks optimized protocols, advanced use-cases, and troubleshooting insights to maximize the performance of APExBIO's industry-leading FLAG tag Peptide.

• U-73122: Advanced PLC Pathway Modulation in Cancer Invasion

  2026-05-13

  Explore how U-73122, a potent phospholipase C inhibitor, enables precise dissection of cancer invasion mechanisms through PLC pathway modulation. This article offers unique assay design insights, bridging advanced mechanistic understanding with translational research needs.

• Asymmetric HflK/C Assemblies Enable FtsH Proteolysis in E. c

  2026-05-13

  This study reveals that native HflK/C forms an asymmetric nautilus-like complex, rather than the symmetric cages seen in overexpression systems, allowing FtsH protease access to membrane-embedded substrates. The findings redefine our understanding of membrane protein degradation and have practical implications for designing affinity tag-based purification and detection strategies.

• TBXA2R-ERM Axis Drives Metastasis in Triple-Negative Breast

  2026-05-12

  This study identifies the thromboxane A2 receptor (TBXA2R) as a key activator of ezrin, radixin, and moesin (ERM) proteins, promoting motility, invasion, and metastasis in triple-negative breast cancer (TNBC) cells. The findings delineate a novel GPCR-driven signaling pathway underlying metastatic dissemination, with implications for targeted therapy development.

• Biotin-tyramide in TSA: Enhanced IHC & ISH Signal Amplificat

  2026-05-12

  Harness the power of Biotin-tyramide for ultrasensitive and spatially precise biomarker detection in immunohistochemistry and in situ hybridization workflows. Learn how APExBIO's high-purity reagent delivers robust, reproducible results and discover expert troubleshooting strategies to maximize your signal-to-noise ratio.

• Unraveling RNA Synthesis Complexity with HyperScribe SP6 Kit

  2026-05-11

  Explore the advanced capabilities of the HyperScribe SP6 High Yield RNA Synthesis Kit in dissecting viral immune evasion and supporting next-generation RNA research. This article uniquely integrates mechanistic bench insights and translational impacts, providing a deeper perspective for SP6 RNA polymerase kit users.

• MLN8237 (Alisertib): Dissecting Aurora A’s Role in Trained I

  2026-05-11

  Explore how MLN8237 (Alisertib), a selective Aurora A kinase inhibitor, goes beyond tumor inhibition to illuminate the intersection of cell cycle control and innate immune memory. This article uniquely bridges mechanistic insights with practical assay guidance, setting it apart from standard cancer biology resources.

8513 records 13/568 page Previous Next First page 上5页 1112131415 下5页 Last page